New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies – making them more vulnerable to a severe infection.
Net prices for medicines fell considerably in 2023’s last quarter, mostly thanks to Humira biosimilars
The net prices that health plans paid for medicines — after subtracting rebates, discounts, and fees — fell by 2.8% in last year’s fourth quarter,
April 1, 2024